NCT04866160View on ClinicalTrials.gov

A Trial in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 17, 2021

Primary Completion Date

November 30, 2021

Study Completion Date

November 30, 2021

Conditions
Healthy
Interventions
DRUG

BI 1291583

BI 1291583

DRUG

Placebo

Placebo

Trial Locations (1)

30625

Fraunhofer ITEM, Hanover

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04866160 - A Trial in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated | Biotech Hunter | Biotech Hunter